All XRAYs
Relevance: Medium-High
Strength of Science: High
28 June 2023
Study : Breast cancer disparities among the LGBTQ+ community
Most relevant for: People belonging to the LGBTQ+ community
This study looked at differences in breast cancer treatment outcomes among people from the LGBTQ+ community. (Posted 6/28/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
8 June 2023
Guideline : What is breast density and why does it matter?
Most relevant for: People who have mammograms
New FDA guidelines for mammograms will go into effect by September 2024. Current FDA guidance requires hospitals and breast centers to give people information about their breast density with their mammogram results. By September 2024, mammogram providers will need to relay to patients who have dense breast that they should discuss the need for additional imaging. This article provides an overview of what breast density means and why it matters. (Posted 6/8/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium
31 May 2023
Topic : Impact of new laws on cancer treatment during pregnancy
Most relevant for: People who have cancer who are pregnant
The U.S. Supreme Court ruled in 2022 that abortion is no longer a protected right under the Constitution. This landmark decision leaves regulation of abortion to the states. Cancer treatment during pregnancy may now be impacted in states that have abortion bans or limitations. (Posted 5/31/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Quality of Writing: High
17 May 2023
Article : A food lover’s decision to remove her stomach highlights difficult decisions around cancer risk
Most relevant for: People with a CDH1 mutation or a family history of stomach cancer
National Public Radio reporter Sáša Woodruff shares her story of learning about her CDH1 mutation and making a decision about risk-reducing surgery. Mutations in the CDH1 gene significantly increase a person’s risk of stomach and breast cancers. Woodruff’s personal essay describes the psychological challenge of making decisions about risk-reducing surgeries and draws attention to a lesser-known mutation linked to hereditary cancer. (Posted 5/17/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium
Strength of Science: Medium-High
Research Timeline: Human Research
3 May 2023
Study : Early removal of ovaries may be linked to small increase in risk of Parkinson’s disease in later life
Most relevant for: Women considering risk-reducing removal of both ovaries
The lifetime risk of developing Parkinson’s disease is low. However, having surgery to remove both ovaries before natural menopause can slightly increase the risk of Parkinson's disease later in life. Researchers studied over 20 years of medical records, which confirmed this small increase in risk, particularly for women who have their ovaries removed before age 43. (Posted 5/3/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Strength of Science: Medium
Research Timeline: Human Research
28 April 2023
Study : Hormonal birth control may reduce ovarian cancer risk in people with BRCA mutations
Most relevant for: Women with BRCA1 or BRCA2 mutations who are interested in reducing their ovarian cancer risk
Hormonal birth control pill is linked to reduced ovarian cancer among people with an inherited BRCA mutation. Longer-acting forms of birth control given by implant, injection or as an intrauterine device may be associated with lower ovarian cancer risk for people with an inherited BRCA mutation. (Posted 4/28/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium
Strength of Science: Medium-High
Research Timeline: Human Research
18 April 2023
Study : Hair straightening products linked to small increased risk of endometrial cancer
Most relevant for: People who use hair straightening products
Many people use products to straighten their hair. Use of these products, especially frequent use, is linked to a small increase in endometrial cancer. (Posted 4/18/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Strength of Science: Medium-High
Research Timeline: Post Approval
7 April 2023
Study : Breast cancer outcomes improved with CDK4/6 inhibitor treatment
Most relevant for: People with HR-positive HER2-negative advanced breast cancer
A study showed that people with metastatic breast cancer who took an oral drug known as a CDK4/6 inhibitor combined with hormone therapy did better than people who took hormone therapy alone. The drug combination improved the length of time before cancer worsened or returned. After six years of treatment, people who took this drug combination lived longer compared to those who took hormone therapy alone. (Posted 4/5/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium
Strength of Science: Medium
Research Timeline: Animal Studies
30 March 2023
Study : Weight may affect breast cancer risk in women with an inherited BRCA mutation
Most relevant for: People with an inherited mutation in BRCA1 or BRCA2 concerned about their breast cancer risk
A study that looked at normal breast cells from women with an inherited BRCA mutation found more DNA damage among women who were overweight (based on a measurement known as body mass index) than those who were not overweight. The results suggest that maintaining a lower weight may reduce breast cancer among this high-risk population. (Posted 3/30/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Strength of Science: High
Research Timeline: Post Approval
20 March 2023
Study : New oral drug treatment for some advanced breast cancer
Most relevant for: People with HR-positive, HER2-negative advanced breast cancer
The FDA has approved a new oral drug called Oserdu for the treatment of HR-positive, HER2-negative advanced breast cancer. A blood test was also approved to help doctors identify patients who would benefit most from this new treatment. (Posted 3/20/23)
Este artículo está disponible en español.
READ MORE ›